| 21 Aug 2026, 00:22 | Initial Director's Interest Notice - Paul FIeld | Director Interests | — | 02008 |
| 21 Aug 2026, 00:21 | Final Director's Interest Notice - Alistair Bennallack | Director Interests | — | 02010 |
| 19 Aug 2026, 19:21 | IVX Credentialed International Biotech Leader Joins Board | Company Administration | — | 12001 |
| 31 July 2026, 23:03 | Appendix 4C and Quarterly Activities Report - June 2026 | Quarterly Reports | MS | 19004, 19009 |
| 22 June 2026, 20:55 | Notification regarding unquoted securities - IVX | Other | — | 06021 |
| 22 June 2026, 20:52 | Application for quotation of securities - IVX | Other | — | 06020 |
| 22 June 2026, 19:24 | Global PDT Leader Dr Colin Hopper Appointed Clinical Advisor | Company Administration | — | 12008 |
| 19 June 2026, 20:48 | Change of Directors' Interest Notices x 3 | Director Interests | — | 02009 |
| 17 June 2026, 02:14 | Notification regarding unquoted securities - IVX | Other | — | 06021 |
| 13 June 2026, 01:03 | Notification regarding unquoted securities - IVX | Other | — | 06021 |
| 13 June 2026, 01:01 | Notification regarding unquoted securities - IVX | Other | — | 06021 |
| 13 June 2026, 00:54 | Notification regarding unquoted securities - IVX | Other | — | 06021 |
| 13 June 2026, 00:45 | Application for quotation of securities - IVX | Other | — | 06020 |
| 30 May 2026, 03:10 | Results of Extraordinary General Meeting | Meetings & Governance | — | 08003 |
| 19 May 2026, 19:21 | Photosoft Platform Expands to Eye Diseases Via Partnership | Company Update | MS | 11001 |
| 12 May 2026, 02:25 | Correction to Appendix 3Y - Alistair Bennallack | Director Interests | — | 02009 |
| 2 May 2026, 00:40 | Notification of cessation of securities - IVX | Other | — | 06027 |
| 30 Apr 2026, 21:40 | Appendix 4C and Quarterly Activities Report - March 2026 | Quarterly Reports | MS | 19003, 19008 |
| 28 Apr 2026, 20:54 | Notice of General Meeting/Proxy Form | Presentations | — | 08004, 08007, 14014, 16002 |
| 22 Apr 2026, 18:51 | Bionnova 2026 Investor Presentation | Presentations | — | 03026 |
| 21 Apr 2026, 19:46 | Skin Cancer Trial Moves to BCC With More Encouraging Signals | Company Update | MS | 11001 |
| 20 Apr 2026, 22:19 | Appendix 3Y Clarification | Company Administration | — | 12008 |
| 20 Apr 2026, 22:17 | Change of Director's Interest Notice - Thian Chew | Director Interests | — | 02009 |
| 8 Apr 2026, 21:04 | Change of Substantial Holding | Substantial Holders | — | 02002 |
| 23 Mar 2026, 22:09 | Proposed issue of securities - IVX | Securities Administration | — | 06013 |
| 23 Mar 2026, 22:06 | Proposed issue of securities - IVX | Securities Administration | — | 06013 |
| 23 Mar 2026, 22:06 | Proposed issue of securities - IVX | Securities Administration | — | 06013 |
| 23 Mar 2026, 22:04 | Proposed issue of securities - IVX | Securities Administration | — | 06013 |
| 19 Mar 2026, 03:48 | Proposed issue of securities - IVX | Securities Administration | — | 06013 |
| 12 Mar 2026, 22:22 | Notification regarding unquoted securities - IVX | Other | — | 06021 |
| 5 Mar 2026, 23:48 | Section 708A Cleansing Statement | Securities Administration | — | 06018 |
| 5 Mar 2026, 23:43 | Application for quotation of securities - IVX | Other | — | 06020 |
| 5 Mar 2026, 20:48 | Cleansing Notice - Convertible Notes | Securities Administration | — | 06009, 06018 |
| 5 Mar 2026, 20:39 | Notification regarding unquoted securities - IVX | Other | — | 06021 |
| 27 Feb 2026, 20:32 | Appendix 4D and Half Year Financial Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 |
| 19 Feb 2026, 20:00 | Emergence 2026 Investor Presentation | Presentations | — | 03026 |
| 19 Feb 2026, 19:52 | Notification regarding unquoted securities - IVX | Other | — | 06021 |
| 31 Jan 2026, 05:18 | Appendix 4C and Quarterly Activities Report - December 2025 | Quarterly Reports | MS | 19002, 19007 |
| 31 Jan 2026, 05:15 | Proposed issue of securities - IVX | Securities Administration | — | 06013 |
| 31 Jan 2026, 05:14 | Proposed issue of securities - IVX | Securities Administration | — | 06013 |
| 31 Jan 2026, 05:14 | Major Shareholders Lead Invion $1.3M Capital Raise | Securities Administration | MS | 06009, 09014 |
| 29 Jan 2026, 21:00 | Trading Halt | Trading Halt / Suspension | MS | 09007 |
| 29 Jan 2026, 20:44 | Pause in Trading | Trading Halt / Suspension | MS | 09005 |
| 13 Jan 2026, 22:08 | Notification of cessation of securities - IVX | Other | — | 06027 |
| 23 Dec 2025, 20:37 | Hanlim & Korean Government Fund Pathway to Clinical Trial | Company Update | MS | 11001 |
| 3 Dec 2025, 19:43 | Invion Secures Expanded Photosoft Global Exclusive License | Company Update | MS | 11001 |
| 27 Nov 2025, 02:20 | Results of Annual General Meeting | Meetings & Governance | — | 08003 |
| 26 Nov 2025, 23:33 | AGM Presentation | Presentations | — | 03026, 15002 |
| 1 Nov 2025, 00:09 | Notification regarding unquoted securities - IVX | Other | — | 06021 |
| 31 Oct 2025, 20:14 | Appendix 4C and Quarterly Activities Report - September 2025 | Quarterly Reports | MS | 19001, 19006 |